L & S Advisors’s Accendra Health ACH Stock Holding History

L & S Advisors’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,000	Closed	-$91K	–	317
2020 Q1	$91K	Buy	+10,000	New	+$60.4K	0.02%	253

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SGCIA

Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

L & S Advisors's ACH Position: Q2 2020 in Review

L & S Advisors sold out of Accendra Health (ACH) in Q2 2020, closing a stake of 10,000 shares — an estimated $91K sold.

L & S Advisors first reported a position in ACH in Q1 2020 and held it in 1 quarter. The position peaked at $91K in Q1 2020. 188 funds tracked by Wall St. Rank hold ACH as of Q2 2020.

L & S Advisors reported no remaining Accendra Health position as of Q2 2020 after selling out during the quarter.
L & S Advisors sold 10,000 Accendra Health shares in Q2 2020, an estimated $91K.
L & S Advisors first reported a position in Accendra Health in Q1 2020 and held it in 1 quarter.
L & S Advisors's Accendra Health position peaked at $91K in Q1 2020.
188 funds tracked by Wall St. Rank held Accendra Health as of Q2 2020.

Based on L & S Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.